🇺🇸 FDA
Pipeline program

5μg/ml ESAT6-CFP10

EC-IIb-healthy

Phase 2 mab completed

Quick answer

5μg/ml ESAT6-CFP10 for Tuberculosis is a Phase 2 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Tuberculosis
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials